Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,069 JPY | -0.49% | -1.69% | +0.37% |
03:16pm | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
10:21am | Takeda Pharmaceutical Receives FDA Approval for Single-Dose Injection Crohn's Disease Treatment | MT |
Sales 2024 * | 4,071B 26.33B | Sales 2025 * | 3,993B 25.83B | Capitalization | 6,415B 41.5B |
---|---|---|---|---|---|
Net income 2024 * | 143B 925M | Net income 2025 * | 236B 1.53B | EV / Sales 2024 * | 2.5 x |
Net Debt 2024 * | 3,771B 24.39B | Net Debt 2025 * | 3,438B 22.24B | EV / Sales 2025 * | 2.47 x |
P/E ratio 2024 * |
43.7
x | P/E ratio 2025 * |
27.3
x | Employees | 49,095 |
Yield 2024 * |
4.6% | Yield 2025 * |
4.64% | Free-Float | 99.12% |
Latest transcript on Takeda Pharmaceutical Company Limited
1 day | -0.49% | ||
1 week | -1.86% | ||
Current month | -2.75% | ||
1 month | -7.06% | ||
3 months | -6.35% | ||
6 months | -6.74% | ||
Current year | +0.37% |
Managers | Title | Age | Since |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 14-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 22-01-31 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 16-05-31 | |
Ian Clark
BRD | Director/Board Member | 62 | 18-12-31 |
Steven Gillis
BRD | Director/Board Member | 71 | 18-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
24.44% | 15 M€ | +4.29% | ||
5.00% | 284 M€ | +19.99% | ||
3.80% | 1,552 M€ | +15.46% | ||
3.43% | 251 M€ | +13.08% | ||
3.26% | 57 M€ | +15.75% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 4,069 | -0.49% | 5 442 500 |
24-04-18 | 4,089 | +0.79% | 3,126,800 |
24-04-17 | 4,057 | -1.55% | 3,273,600 |
24-04-16 | 4,121 | +0.63% | 4,281,700 |
24-04-15 | 4,095 | -1.23% | 3,518,400 |
Delayed Quote Japan Exchange, April 19, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.37% | 41.5B | |
+27.67% | 672B | |
+24.68% | 550B | |
-6.76% | 351B | |
+15.01% | 317B | |
+6.58% | 292B | |
+2.83% | 211B | |
0.00% | 203B | |
-11.58% | 144B | |
-8.43% | 141B |
- Stock Market
- Equities
- 4502 Stock